VALEO PHARMA CLOSES $4.5 MILLION FINANCING

VALEO PHARMA CLOSES $4.5 MILLION FINANCING

$3.92 million raised from non-brokered private placement offering, and $0.58 million from insider loan Investissement Québec and insiders each invest $2.0 million Proceeds from the financing to be used to strengthen working capital and  support ongoing growth...
VALEO PHARMA ANNOUNCES NEW BOARD APPOINTMENTS

VALEO PHARMA ANNOUNCES NEW BOARD APPOINTMENTS

MONTREAL, QUEBEC, June 22, 2023 – Valeo Pharma Inc. (TSX: VPH, OTCQB: VPHIF, FSE: VP2) (“Valeo” or the “Company”), a Canadian pharmaceutical company, today announced that Ms. Tamara Close and Mr. Didier Leconte have joined its Board of Directors. Following the...